Inclusion Criteria:

- Written informed consent has been obtained from the subject prior to FS VH S/D
administration

- Female subjects >= 19 years of age

- Subjects with breast cancer scheduled to undergo lumpectomy of the breast and level I
and II axillary lymphadenectomy with two separate incisions

Exclusion Criteria:

- Subjects with known hypersensitivity to aprotinin or other components of the product

- Subjects with immunodeficiency

- Subjects with increased red cell production (e.g., in hemolytic anemia)

- Subjects with coagulation disorders shown by exceeding the normal range of any of
following: prothrombin time (PT), Quick, activated partial thromboplastin time
(aPTT), fibrinogen level, or thrombocytes.

- Subjects having previously had axillary surgery

- Subjects having undergone irradiation therapy to the axillary tissue

- Subjects having ever received chemotherapy before the surgery